Your browser doesn't support javascript.
loading
Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia.
Chaturvedi, Anuhar; Gupta, Charu; Gabdoulline, Razif; Borchert, Nora M; Goparaju, Ramya; Kaulfuss, Stefan; Görlich, Kerstin; Schottmann, Renate; Othman, Basem; Welzenbach, Julia; Panknin, Olaf; Wagner, Markus; Geffers, Robert; Ganser, Arnold; Thol, Felicitas; Jeffers, Michael; Haegebarth, Andrea; Heuser, Michael.
Afiliação
  • Chaturvedi A; Hannover Medical School, Hannover, Germany.
  • Gupta C; Hannover Medical School, Hannover, Germany.
  • Gabdoulline R; Hannover Medical School, Hannover, Germany.
  • Borchert NM; Hannover Medical School, Hannover, Germany.
  • Goparaju R; Hannover Medical School, Hannover, Germany.
  • Kaulfuss S; Bayer AG, Berlin, Germany.
  • Görlich K; Hannover Medical School, Hannover, Germany.
  • Schottmann R; Hannover Medical School, Hannover, Germany.
  • Othman B; Hannover Medical School, Hannover, Germany.
  • Welzenbach J; School of Medicine and University Hospital Bonn.
  • Panknin O; Bayer AG, Berlin, Germany.
  • Wagner M; Bayer AG, Berlin, Germany.
  • Geffers R; Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Ganser A; Hannover Medical School, Hannover, Germany.
  • Thol F; Hannover Medical School, Hannover, German.
  • Jeffers M; Bayer AG, Whippany, NJ, USA.
  • Haegebarth A; Bayer AG, Berlin, Germany.
  • Heuser M; Hannover Medical School, Hannover, Germany.
Haematologica ; 106(2): 565-573, 2021 02 01.
Article em En | MEDLINE | ID: mdl-32241846

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article